Gene Therapy for Cardiovascular Diseases

Gene therapy is emerging as a potential strategy for the treatment of cardiovascular diseases, such as peripheral arterial disease, ischemic heart disease, restenosis after angioplasty, vascular bypass graft occlusion and transplant-associated coronary artery disease. Discover the latest research on gene therapy for cardiovascular diseases here.

September 16, 2021

Current status of cardiac manifestations in Fabry disease and their treatment.

Medicine and Pharmacy Reports
Dan RadulescuMaria L Radulescu
September 16, 2021
Comment / Editorial

The long and winding road of reverse genetics in Trypanosoma cruzi.

Microbial Cell
Miguel A Chiurillo, Noelia Lander
September 16, 2021
Review
Open Access

Adding a "Notch" to Cardiovascular Disease Therapeutics: A MicroRNA-Based Approach.

Frontiers in Cell and Developmental Biology
Luisa MarracinoPaola Rizzo
September 16, 2021
Case Report
Open Access

Moyamoya disease associated with pediatric pulmonary hypertension-a case report.

Cardiovascular Diagnosis and Therapy
Johannes KrämerChristian Apitz
September 16, 2021

Cardiomyopathy, Proximal Myopathy, Camptocormia, and Novel Filamin C (FLNC) Variant: A Case Report.

The American Journal of Case Reports
Sara Jasmin HooshmandBrian P Bostick
September 16, 2021

Genetic and epigenetic mechanisms involved in bariatric surgery.

Annali italiani di chirurgia
Ciprian CucoreanuGeorge Calin Dindelegan
September 16, 2021

Introducer Design Concepts for an Epicardial Parallel Wire Robot.

Robotic Surgery : Research and Reviews
Aman LadakCameron N Riviere
September 16, 2021

Single-cell RNA sequencing of peripheral blood mononuclear cells from acute Kawasaki disease patients.

Nature Communications
Zhen WangMin Huang
September 15, 2021
Case Report

A Case of a 49-Year-Old Man with Nonclassical Fabry Disease Diagnosed by Renal Biopsy.

Nephron
Lanjun FuLingzhi He
September 15, 2021
Review

The genetics of cardiac amyloidosis.

Heart Failure Reviews
Scott Arno, Jennifer Cowger
September 15, 2021

CRISPR-Cas9 genome engineering: trends in medicine and health.

Mini Reviews in Medicinal Chemistry
Sumera ZaibImtiaz Khan
September 14, 2021

Gene Therapy: Targeting Cardiomyocyte Proliferation to Repopulate the Ischemic Heart.

Journal of Cardiovascular Pharmacology
Ayelén Emilce LópezPaola Locatelli
September 14, 2021

Preclinical short QT syndrome models: studying the phenotype and drug-screening.

Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology
Xuehui FanIbrahim El-Battrawy
September 14, 2021
Review

The emerging role of miRNA-132/212 cluster in neurologic and cardiovascular diseases: Neuroprotective role in cells with prolonged longevity.

Mechanisms of Ageing and Development
Rachid El FatimyLuc Rochette
September 14, 2021
Review

Small Intestinal Phosphate Absorption: Novel Therapeutic Implications.

American Journal of Nephrology
Jerry YeeStuart M Sprague
September 14, 2021
Review

Analysis of the gut microbiome in dogs and cats.

Veterinary Clinical Pathology
Jan S Suchodolski
September 14, 2021

Gene Therapy for Duchenne Muscular Dystrophy.

Journal of Neuromuscular Diseases
Nertiyan Elangkovan, George Dickson
September 13, 2021
Review

Modifying strategies for SDF-1/CXCR4 interaction during mesenchymal stem cell transplantation.

General Thoracic and Cardiovascular Surgery
Qin JiangShengshou Hu
September 11, 2021
Open Access

Chicken bone marrow mesenchymal stem cells improve lung and distal organ injury.

Scientific Reports
Hexuan NiuXishuai Wang

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused by a partial deletion of chromosome 22. Symptoms include heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood, and delayed development. Discover the latest research on this disease here.

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Antisense Oligonucleotide Therapies: ND

Antisense oligonucleotides are synthetic DNA oligomers that hybridize to a target RNA. This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

© 2021 Meta ULC. All rights reserved
/feed-previews/gene-therapy-for-cardiovascular/566aab88-c9d7-4780-bfa7-e6d247c5ae2d